M&T Bank Corp Has $2.10 Million Stock Holdings in Acadia Healthcare Company, Inc. $ACHC

Key Points

• M&T Bank Corp increased its stake in Acadia Healthcare by 666.3% in Q4 to 148,057 shares, valued at about $2.10 million (≈0.16% of the company).
• Large institutions hold substantial positions—Wellington and Vanguard each own roughly 9.42 million shares (~$233 million), while UBS, Abrams Bison and State Street also recently increased their stakes.
• Analysts are mixed with a consensus rating of "Hold" and a target of $22.65; the stock traded around $27.58 after Acadia posted an earnings beat (Q EPS $0.07 vs $0.03) and issued FY2026 guidance of 1.30–1.55 EPS.

M&T Bank Corp boosted its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 666.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 148,057 shares of the company's stock after buying an additional 128,737 shares during the quarter. M&T Bank Corp owned approximately 0.16% of Acadia Healthcare worth $2,101,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently made changes to their positions in the stock. Wellington Management Group LLP increased its position in shares of Acadia Healthcare by 11.8% during the 3rd quarter. Wellington Management Group LLP now owns 9,423,548 shares of the company's stock worth $233,327,000 after purchasing an additional 993,205 shares during the last quarter. Vanguard Group Inc. increased its position in shares of Acadia Healthcare by 7.8% during the 3rd quarter. Vanguard Group Inc. now owns 9,417,045 shares of the company's stock worth $233,166,000 after purchasing an additional 681,278 shares during the last quarter. Abrams Bison Investments LLC increased its position in shares of Acadia Healthcare by 22.3% during the 3rd quarter. Abrams Bison Investments LLC now owns 4,380,000 shares of the company's stock worth $108,449,000 after purchasing an additional 800,000 shares during the last quarter. UBS Group AG increased its position in shares of Acadia Healthcare by 8.8% during the 3rd quarter. UBS Group AG now owns 4,336,698 shares of the company's stock worth $107,377,000 after purchasing an additional 350,484 shares during the last quarter. Finally, State Street Corp increased its position in shares of Acadia Healthcare by 3.2% during the 2nd quarter. State Street Corp now owns 3,095,775 shares of the company's stock worth $70,243,000 after purchasing an additional 95,670 shares during the last quarter.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on ACHC shares. Raymond James Financial reaffirmed an "outperform" rating and set a $25.00 price target on shares of Acadia Healthcare in a research report on Thursday, February 26th. Guggenheim lowered their price target on Acadia Healthcare from $27.00 to $22.00 and set a "buy" rating on the stock in a research report on Monday, February 23rd. UBS Group boosted their target price on Acadia Healthcare from $27.00 to $31.00 and gave the stock a "buy" rating in a report on Friday, April 17th. Leerink Partners boosted their target price on Acadia Healthcare from $14.00 to $22.00 and gave the stock a "market perform" rating in a report on Thursday, February 26th. Finally, Barclays boosted their target price on Acadia Healthcare from $14.00 to $20.00 and gave the stock an "equal weight" rating in a report on Tuesday, March 3rd. Seven equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $22.65.

Acadia Healthcare Stock Performance

ACHC opened at $27.58 on Wednesday. The business has a fifty day simple moving average of $24.02 and a 200 day simple moving average of $19.09. The company has a market capitalization of $2.54 billion, a PE ratio of -2.26, a price-to-earnings-growth ratio of 9.51 and a beta of 0.71. Acadia Healthcare Company, Inc. has a 1 year low of $11.43 and a 1 year high of $28.49. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.55 and a quick ratio of 1.55.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings results on Wednesday, February 25th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.04. The business had revenue of $821.46 million during the quarter, compared to the consensus estimate of $800.10 million. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.The firm's quarterly revenue was up 6.1% on a year-over-year basis. During the same period in the previous year, the company posted $0.64 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. Research analysts expect that Acadia Healthcare Company, Inc. will post 1.48 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.